Understanding Solid State Properties for Formulation Success

ALCAMI Webinar reviews critical drug substance considerations.

In Alcami’s experience, understanding the solid-state properties of a drug candidate molecule is essentially important for successful dosage form development. To avoid process instability, close collaboration and communication between solid-state characterization scientists, synthetic process chemists, analysts and engineers, and formulation development personnel is virtually a prerequisite.

Designed to meet development and integration challenges head on, Alcami’s April 6 Webinar will present ProForm Select™ the CDMO’s unique offering designed to provide pharma and biotech companies an integrated, end-to-end control strategy proven to reduce process instability. From development to clinical and commercial, Alcami says their service offers an innovative in-parallel integration of API process chemistry and Drug Product formulation development, a combination effective at driving right-first-time results.

The webinar, scheduled for 3:00pm–4:00pm EDT (GMT04:00) Thursday, April 6, will present the ProForm Select™ offering and cover how the platform can provide solutions to drug owner’s biggest development challenges including selection, API process optimization, drug product formulation and end-to-end control of the manufacturing process.

To register click here.

 

 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.